FI931157A0 - 5-TRIFLUORACYLAMINO-2-ARYLOXATZOLER - Google Patents

5-TRIFLUORACYLAMINO-2-ARYLOXATZOLER

Info

Publication number
FI931157A0
FI931157A0 FI931157A FI931157A FI931157A0 FI 931157 A0 FI931157 A0 FI 931157A0 FI 931157 A FI931157 A FI 931157A FI 931157 A FI931157 A FI 931157A FI 931157 A0 FI931157 A0 FI 931157A0
Authority
FI
Finland
Prior art keywords
trifluoracylamino
aryloxatzoler
Prior art date
Application number
FI931157A
Other languages
Finnish (fi)
Other versions
FI931157A (en
Inventor
David A Clark
Harry R Howard
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI931157A publication Critical patent/FI931157A/en
Publication of FI931157A0 publication Critical patent/FI931157A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI931157A 1990-09-17 1993-03-16 5-TRIFLUORACYLAMINO-2-ARYLOXATZOLER FI931157A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58342590A 1990-09-17 1990-09-17
PCT/US1991/005172 WO1992005163A1 (en) 1990-09-17 1991-07-29 5-trifluoroacylamino-2-aryl oxazoles

Publications (2)

Publication Number Publication Date
FI931157A FI931157A (en) 1993-03-16
FI931157A0 true FI931157A0 (en) 1993-03-16

Family

ID=24333046

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931157A FI931157A0 (en) 1990-09-17 1993-03-16 5-TRIFLUORACYLAMINO-2-ARYLOXATZOLER

Country Status (7)

Country Link
EP (1) EP0549600A1 (en)
JP (1) JPH0667915B2 (en)
CA (1) CA2090857A1 (en)
FI (1) FI931157A0 (en)
IE (1) IE913254A1 (en)
PT (1) PT98981A (en)
WO (1) WO1992005163A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2547895A (en) * 1994-05-13 1995-12-05 Sanofi Winthrop, Inc. Therapeutic phenoxyalkylheterocycles
US5631379A (en) * 1994-11-22 1997-05-20 American Cyanamid Company Oxazole amines as intermediates in the manufacture of insecticidal pyrroles
US5763461A (en) * 1995-05-26 1998-06-09 Sanofi Therapeutic phenoxyalkylheterocycles
US6228871B1 (en) * 1995-07-10 2001-05-08 Merck & Co., Inc. Angiogenesis inhibitors
JPH0932835A (en) * 1995-07-18 1997-02-04 Takeshi Kameyama Locking of screw
US6667327B2 (en) 2002-02-04 2003-12-23 Hoffmann-La Roche Inc. Pyridine amido derivatives
BRPI0415842A (en) 2003-10-23 2007-01-02 Hoffmann La Roche benzapepine derivatives as mao-b inhibitors
SG11202008739TA (en) * 2018-04-12 2020-10-29 Bayer Ag N-(cyclopropylmethyl)-5-(methylsulfonyl)-n-{1-[1-(pyrimidin-2-yl)-1h-1,2,4-triazol-5-yl]ethyl}benzamide derivatives and the corresponding pyridine-carboxamide derivatives as pesticides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications

Also Published As

Publication number Publication date
JPH05506244A (en) 1993-09-16
FI931157A (en) 1993-03-16
WO1992005163A1 (en) 1992-04-02
JPH0667915B2 (en) 1994-08-31
PT98981A (en) 1992-07-31
IE913254A1 (en) 1992-02-25
EP0549600A1 (en) 1993-07-07
CA2090857A1 (en) 1992-03-18

Similar Documents

Publication Publication Date Title
ATA150090A (en) HOERGERAET
NO179545B (en) Konstruksjonsleketöysystem
FI931369A0 (en) FLYTANDE DETERGENTKOMPOSITIONER
FI930295A0 (en) HAORFORMNINGSGELKOMPOSITION
DK0538381T3 (en) Speaker-suspension
FI932636A0 (en) Monteringsunderlag Foer gejdstaenger
FI932841A (en) FIXERINGSKOMPOSITIONER FOER TANDPROTES
NO171087C (en) SJOEVANNCELLE
FI931125A0 (en) FODRING
FI931157A (en) 5-TRIFLUORACYLAMINO-2-ARYLOXATZOLER
FI931906A (en) TUNNSKIKTS EL-ANORDNING
FI930816A0 (en) HJULUPPHAENGNINGSANORDNING
FI932197A (en) Semduramicinfoerblandning
FI932627A0 (en) Hoegspaenningstransformator Foer en tv-apparat
FI925611A (en) HETEROCYCLISKA ANTRACYKLIDON- OCH ANTRACYKLINANALOGER
ATA80690A (en) ALPINSCHI
SE9102447L (en) ROERKOPPLING
ATA200090A (en) PIANINO
FI925540A0 (en) SKAFT FOER GOLFKLUBBA
FI932807A (en) BRAENSLEELEMENT FOER KAERNREAKTOR
BR9101437A (en) COPOLIESTER
ATA237490A (en) RINNENSTEIN
FI932846A (en) HETEROCYCLISKA PESTICIDA FOERENINGAR
FI88435B (en) KONTINUERLIGT ARBETANDE TRUMPRESSTORK
BR9003611A (en) HYDROBALIATOR

Legal Events

Date Code Title Description
FD Application lapsed